275,393 Shares in Alignment Healthcare, Inc. $ALHC Bought by Edgestream Partners L.P.

Edgestream Partners L.P. bought a new stake in Alignment Healthcare, Inc. (NASDAQ:ALHC) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 275,393 shares of the company’s stock, valued at approximately $4,852,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. California State Teachers Retirement System lifted its position in Alignment Healthcare by 25.4% during the 1st quarter. California State Teachers Retirement System now owns 198,200 shares of the company’s stock worth $3,492,000 after buying an additional 40,135 shares in the last quarter. Quantinno Capital Management LP boosted its stake in shares of Alignment Healthcare by 442.2% during the 1st quarter. Quantinno Capital Management LP now owns 89,387 shares of the company’s stock worth $1,575,000 after buying an additional 72,900 shares during the last quarter. Orbimed Advisors LLC bought a new position in shares of Alignment Healthcare in the 1st quarter valued at about $13,937,000. Granahan Investment Management LLC grew its holdings in shares of Alignment Healthcare by 4.1% in the 1st quarter. Granahan Investment Management LLC now owns 780,500 shares of the company’s stock valued at $13,752,000 after acquiring an additional 31,013 shares in the last quarter. Finally, Renaissance Technologies LLC grew its holdings in shares of Alignment Healthcare by 8.8% in the 1st quarter. Renaissance Technologies LLC now owns 2,903,100 shares of the company’s stock valued at $51,153,000 after acquiring an additional 235,900 shares in the last quarter. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Alignment Healthcare

In related news, insider Hyong Kim sold 35,951 shares of the stock in a transaction on Friday, June 12th. The stock was sold at an average price of $19.86, for a total value of $713,986.86. Following the sale, the insider owned 331,750 shares in the company, valued at approximately $6,588,555. This represents a 9.78% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Mark D. Kent purchased 14,848 shares of the company’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was acquired at an average price of $13.31 per share, for a total transaction of $197,626.88. Following the purchase, the insider owned 14,848 shares in the company, valued at $197,626.88. This trade represents a ∞ increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders sold a total of 1,039,951 shares of company stock worth $19,976,967 in the last three months. 5.20% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on ALHC shares. Barclays dropped their target price on Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 26th. UBS Group restated a “neutral” rating on shares of Alignment Healthcare in a research note on Wednesday, July 8th. KeyCorp reaffirmed an “overweight” rating on shares of Alignment Healthcare in a research report on Wednesday, June 10th. Wolfe Research began coverage on Alignment Healthcare in a research note on Friday, April 17th. They set an “outperform” rating and a $24.00 price objective on the stock. Finally, Raymond James Financial set a $22.00 price objective on Alignment Healthcare in a research note on Thursday, May 7th. Six investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, Alignment Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $24.30.

Key Stories Impacting Alignment Healthcare

Here are the key news stories impacting Alignment Healthcare this week:

• Positive Sentiment: Q2 results exceeded expectations: Alignment reported adjusted earnings of $0.17 per share, above the $0.13 consensus estimate, while revenue of $1.34 billion surpassed estimates of $1.31 billion. Revenue increased 31.6% year over year, and net income more than doubled to $36.6 million as Medicare Advantage care costs improved. Alignment Healthcare Reports Second Quarter 2026 Results
• Positive Sentiment: Operating performance is improving: The company said it surpassed the high end of its guidance across key metrics, reflecting stronger membership growth, revenue, and profitability compared with the prior-year period. Alignment Healthcare Turns Profit
• Neutral Sentiment: Guidance remained broadly in line: Full-year 2026 revenue guidance was approximately $5.2 billion, and third-quarter revenue guidance was approximately $1.3 billion, generally matching analyst expectations. The lack of a material forecast increase may have limited the earnings-driven upside.
• Negative Sentiment: Several law firms announced investigations: Frank R. Cruz, Block & Leviton, Kaplan Fox, Lowey Dannenberg, and Pomerantz publicized inquiries into possible securities-law violations and alleged financial manipulation. The investigations follow an earlier sharp drop in ALHC shares and could create legal costs, reputational damage, and uncertainty regarding the company’s disclosures. The allegations have not been proven. Securities Fraud Investigation Into Alignment Healthcare

Alignment Healthcare Trading Down 20.2%

Alignment Healthcare stock opened at $14.85 on Friday. Alignment Healthcare, Inc. has a 52 week low of $12.91 and a 52 week high of $25.12. The company has a debt-to-equity ratio of 1.56, a quick ratio of 1.58 and a current ratio of 1.58. The stock has a market capitalization of $3.07 billion, a P/E ratio of 78.16, a PEG ratio of 2.51 and a beta of 1.05. The stock has a 50-day simple moving average of $19.70 and a 200 day simple moving average of $19.76.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings results on Thursday, July 30th. The company reported $0.17 earnings per share for the quarter, topping analysts’ consensus estimates of $0.13 by $0.04. The firm had revenue of $1.34 billion for the quarter, compared to the consensus estimate of $1.31 billion. Alignment Healthcare had a return on equity of 22.28% and a net margin of 0.89%.The business’s revenue was up 31.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.07 earnings per share. Analysts expect that Alignment Healthcare, Inc. will post 0.2 earnings per share for the current year.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.